View in EDS

Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study.

Saved in:
Bibliographic Details
Title: Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study.
Authors: Van Den Blink B; Kinevant Sciences, Inc., New York, NY, USA., Birring SS; Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK., Mogulkoc N; Department of Chest Diseases, University of Ege, Izmir, Turkey., Nayci Atis S; Department of Pulmonology, University of Mersin, Mersin, Turkey., Gupta R; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA., Guiot J; Department of Respiratory Medicine, CHU Liège, Liège, Belgium., Hart SP; Respiratory Research Group, Hull York Medical School/University of Hull, Cottingham, UK., Carmona Porquera EM; Department of Pulmonary Medicine, Mayo Clinic, Rochester, MN, USA., Koeller HB; Kinevant Sciences, Inc., New York, NY, USA., Arocho N; Kinevant Sciences, Inc., New York, NY, USA., Petit CM; Kinevant Sciences, Inc., New York, NY, USA., Denning J; Kinevant Sciences, Inc., New York, NY, USA., Lin M; Roivant Sciences, Inc., New York, NY, USA., Baughman RP; Department of Medicine, University of Cincinnati, Cincinnati, OH, USA., Wijsenbeek-Lourens M; Center for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Reiss TF; Kinevant Sciences, Inc., New York, NY, USA ted.reiss@roivant.com.
Corporate Authors: RESOLVE-Lung investigators
Source: The European respiratory journal [Eur Respir J] 2026 Jul 09; Vol. 68 (1). Date of Electronic Publication: 2026 Jul 09 (Print Publication: 2026).
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41819539
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Van+Den+Blink+B%22">Van Den Blink B</searchLink>; Kinevant Sciences, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Birring+SS%22">Birring SS</searchLink>; Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Mogulkoc+N%22">Mogulkoc N</searchLink>; Department of Chest Diseases, University of Ege, Izmir, Turkey.<br /><searchLink fieldCode="AU" term="%22Nayci+Atis+S%22">Nayci Atis S</searchLink>; Department of Pulmonology, University of Mersin, Mersin, Turkey.<br /><searchLink fieldCode="AU" term="%22Gupta+R%22">Gupta R</searchLink>; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Guiot+J%22">Guiot J</searchLink>; Department of Respiratory Medicine, CHU Liège, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Hart+SP%22">Hart SP</searchLink>; Respiratory Research Group, Hull York Medical School/University of Hull, Cottingham, UK.<br /><searchLink fieldCode="AU" term="%22Carmona+Porquera+EM%22">Carmona Porquera EM</searchLink>; Department of Pulmonary Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Koeller+HB%22">Koeller HB</searchLink>; Kinevant Sciences, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Arocho+N%22">Arocho N</searchLink>; Kinevant Sciences, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Petit+CM%22">Petit CM</searchLink>; Kinevant Sciences, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Denning+J%22">Denning J</searchLink>; Kinevant Sciences, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lin+M%22">Lin M</searchLink>; Roivant Sciences, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Baughman+RP%22">Baughman RP</searchLink>; Department of Medicine, University of Cincinnati, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Wijsenbeek-Lourens+M%22">Wijsenbeek-Lourens M</searchLink>; Center for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Reiss+TF%22">Reiss TF</searchLink>; Kinevant Sciences, Inc., New York, NY, USA ted.reiss@roivant.com.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22RESOLVE-Lung+investigators%22">RESOLVE-Lung investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228803460%22">The European respiratory journal</searchLink> [Eur Respir J] 2026 Jul 09; Vol. 68 (1). <i>Date of Electronic Publication: </i>2026 Jul 09 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Respiratory+Society%22">European Respiratory Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8803460 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1399-3003 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209031936%22">09031936 </searchLink><i>NLM ISO Abbreviation: </i>Eur Respir J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41819539
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1183/13993003.01874-2025
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Van Den Blink B
      – PersonEntity:
          Name:
            NameFull: Birring SS
      – PersonEntity:
          Name:
            NameFull: Mogulkoc N
      – PersonEntity:
          Name:
            NameFull: Nayci Atis S
      – PersonEntity:
          Name:
            NameFull: Gupta R
      – PersonEntity:
          Name:
            NameFull: Guiot J
      – PersonEntity:
          Name:
            NameFull: Hart SP
      – PersonEntity:
          Name:
            NameFull: Carmona Porquera EM
      – PersonEntity:
          Name:
            NameFull: Koeller HB
      – PersonEntity:
          Name:
            NameFull: Arocho N
      – PersonEntity:
          Name:
            NameFull: Petit CM
      – PersonEntity:
          Name:
            NameFull: Denning J
      – PersonEntity:
          Name:
            NameFull: Lin M
      – PersonEntity:
          Name:
            NameFull: Baughman RP
      – PersonEntity:
          Name:
            NameFull: Wijsenbeek-Lourens M
      – PersonEntity:
          Name:
            NameFull: Reiss TF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 07
              Text: 2026 Jul 09
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1399-3003
          Numbering:
            – Type: volume
              Value: 68
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The European respiratory journal
              Type: main
ResultId 1